跳至主要内容
临床试验/NCT04511507
NCT04511507已完成不适用

Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Liver Failure

Institutul Clinic Fundeni1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2016年2月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
1
主要终点
30 days mortality

研究概览

简要总结

Hemoadsorption has been demonstrated to improve liver functional tests in patients with liver failure. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with acute liver failure, on liver functional tests, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with acute liver failure or acute on chronic liver failure who require hemoadsorption in accordance with local guidelines

排除标准

  • unsigned informed consent
  • duration of therapy under 12 hours
  • death before the three consecutive sessions

结局指标

主要结局

30 days mortality

时间窗: 30 days

30 days mortality

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Popescu Mihai

Clinical Professor

Institutul Clinic Fundeni

研究点 (1)

Loading locations...

相似试验